Evidence map›Paper›PMID 23275077›Full record

ArticleLipids2013

Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection.

Stephan W Reinhold, Thomas Scherl, Benjamin Stölcker, Tobias Bergler, Ute Hoffmann, Christian Weingart, Miriam C Banas, Dmitrij Kollins, Martin C Kammerl, Bernd Krüger and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Lipids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Leukotrienes and kidney diseases.Current opinion in nephrology and hypertension · 2018
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Stephan W ReinholdKlinik und Poliklinik für Innere Medizin II-Nephrologie, Universität Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany. stephan.reinhold@klinik.uni-regensburg.de
Thomas Scherl
Benjamin Stölcker
Tobias Bergler
Ute Hoffmann
Christian Weingart
Miriam C Banas
Dmitrij Kollins
Martin C Kammerl
Bernd Krüger
Bernhard Kaess
Bernhard K Krämer
Bernhard Banas
University Hospital Regensburg · DEUniversity of Regensburg · DEHeidelberg University · DEUniversity Medical Centre Mannheim · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute transplant rejection is the leading cause of graft loss in the first months after kidney transplantation. Lipoxygenase products mediate pro- and anti-inflammatory actions and thus we aimed to correlate the histological reports of renal transplant biopsies with urinary lipoxygenase products concentrations to evaluate their role as a diagnostic marker. This study included a total of 34 kidney transplant recipients: 17 with an acute transplant rejection and 17 controls. LTE4, LTB4, 12-HETE and 15-HETE concentrations were measured by enzyme immunoassay. Urinary lipoxygenase product concentrations were not significantly changed during an acute allograft rejection. Nevertheless, LTB4 concentrations correlated significantly with the body temperature (P ≤ 0.05) 3 months after transplantation, and 12- and 15-HETE concentrations correlated significantly with renal function (P ≤ 0.05) 2 weeks after transplantation. In conclusion, our data show a correlation for LTB4 with the body temperature 3 months after transplantation and urinary 12- and 15-HETE concentrations correlate positively with elevated serum creatinine concentrations but do not predict acute allograft rejection.

Indexed as

Body Temperature12-Hydroxy-5,8,10,14-eicosatetraenoic AcidAcute DiseaseAdultFemaleGraft RejectionHumansHydroxyeicosatetraenoic AcidsKidneyKidney TransplantationLeukotriene B4Leukotriene E4LipoxygenaseMaleMiddle Aged12-Hydroxy-5,8,10,14-eicosatetraenoic Acid15-hydroxy-5,8,11,13-eicosatetraenoic acidHydroxyeicosatetraenoic AcidsLeukotriene B4Leukotriene E4Lipoxygenase

Identifiers

PMID23275077
OpenAlexW1969625693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.